All Pharma articles – Page 28
-
NewsNICE to back use of Lucentis for eye condition
Thousands of people with a devastating eye condition could be offered a potentially sight-saving treatment following a U-turn by the health watchdog.
-
-
NewsMove from branded drugs could save NHS millions
Doctors could save the NHS billions of pounds a year by ditching expensive branded drugs in favour of prescribing cheaper, equally effective alternatives, new research has found.
-
News
Attention deficit drugs bill in seven-fold increase
The health service is facing a growing bill from the record number of people being given drugs to combat attention-deficit hyperactivity disorder (ADHD), figures show.
-
NewsWarning over buying drugs online
The purchase of prescription medicines online without a prescription is increasing, pharmacists have said.
-
NewsSchizophrenia report demands better care
Significant improvements in care are needed if the lives of schizophrenia sufferers are to get better, according to the first national audit for people with the severe mental illness.
-
NewsGP nominated as new NICE chair
One of the country’s most prominent GPs has been named as the government’s preferred candidate to chair the National Institute for Health and Clinical Excellence.
-
NewsDrug chief uncomfortable over fund
A cash pot used to pay for life-extending drugs should not be limited to patients who have cancer, the head of the National Institute for Health and Clinical Excellence has suggested.
-
NewsPatients should pay for 'lifestyle' diseases - Tory MP
Patients suffering from diseases caused by “lifestyle choices” such as diabetes should pay for their medication to help save the NHS from collapse, a Tory GP has urged.
-
NewsQIPP lead: drugs bill will increase
Providers and commissioners need to focus on making sure they achieve value for money on drugs rather than cutting overall spend, the government’s pharmaceutical spending efficiency expert has told HSJ.
-
NewsReport: NHS slipping on Innovation, Health and Wealth targets
There has been a “disappointing” lack of local engagement with the government’s plan to improve the spread of innovation in the NHS, new research has concluded.
-
NewsMedicines body review announced
Concerns about the inconsistent availability of some medicines in Scotland has prompted a review of the decision-making process at the NHS’s drugs approval body.
-
SupplementsDrug action - an HSJ supplement on primary care
From recruitment challenges to a greater role for pharmacies, our supplement probes the latest developments in primary care
-
HSJ KnowledgeWhy pharmacies must think big
If pharmacists fail to grasp the opportunities before them, someone else will
-
HSJ KnowledgeDispense with the old way of doing things
Lack of transparency in the medicines supply chain is of concern to many observers
-
NewsQIPP medicines management schemes get green light
QIPP plans to reduce spending on medicines are making better progress than other major workstreams.
-
NewsGovernment rejects BMA's rationing warning
The government has rejected a warning by the new leader of Britain’s doctors that the health of NHS patients was being put at risk because they were being denied access to operations and drugs.
-
NewsCall to maintain Cancer Drugs Fund
Tens of thousands of cancer sufferers could be denied life-extending drugs unless the government finds a way to continue funding treatment for patients, a charity has warned.
-
HSJ KnowledgeStepping good practice up a gear
HIECs are invaluable in delivering improvement at scale and pace
-
HSJ Local
Commissioners report Lucentis pressure from Newcastle FT
FINANCE: North Tyneside PCT, Northumberland CT and Newcastle PCT are facing overspending risks in relation to Newcastle upon Tyne Hospitals Foundation Trust, largely attributable to use of Lucentis (ranibizumab injection).